RBQM
Risk-Based Quality Management
What a definition is not
A definition is SPEQ’s plain-language decode of how a term is used in practice, cited to the documents that define it. It is a practitioner reference, not legal or regulatory advice, it does not replace the definition in the source, and where a regulator’s wording differs the regulator’s wording governs.
RBQM is the systematic application of risk management across a clinical trial's lifecycle — identifying the factors critical to participant safety and data reliability, assessing and controlling the risks to them, and concentrating oversight where the risk is highest. It replaces uniform, activity-based monitoring with a proportionate model in which effort follows risk. RBQM is the operating philosophy behind risk-based monitoring, centralized statistical surveillance, and quality tolerance limits.
RBQM is not a single tool but a program: a risk assessment (often documented in a risk assessment and categorization tool), a defined set of critical-to-quality factors, quality tolerance limits with pre-specified thresholds, and a monitoring strategy that mixes on-site, remote, and centralized methods.
The discipline is anchored in ICH E8(R1) (general considerations, quality-by-design) and ICH E6 GCP, and is reinforced by regulator guidance on a risk-based approach to monitoring.
- —Effort follows risk — oversight is proportionate, not uniform
- —Centralized/statistical monitoring complements or replaces exhaustive on-site SDV
- —Feeds quality tolerance limits and critical-to-quality factor selection
- —Documented via a risk assessment maintained across the trial lifecycle
ICH E6(R3) Good Clinical Practice; ICH E8(R1) General Considerations for Clinical Studies; FDA guidance "A Risk-Based Approach to Monitoring of Clinical Investigations".
Frequently asked questions
What does RBQM stand for?
RBQM stands for Risk-Based Quality Management.
What is RBQM?
RBQM is the systematic application of risk management across a clinical trial's lifecycle — identifying the factors critical to participant safety and data reliability, assessing and controlling the risks to them, and concentrating oversight where the risk is highest. It replaces uniform, activity-based monitoring with a proportionate model in which effort follows risk. RBQM is the operating philosophy behind risk-based monitoring, centralized statistical surveillance, and quality tolerance limits.
Which regulations cover RBQM?
ICH E6(R3) Good Clinical Practice; ICH E8(R1) General Considerations for Clinical Studies; FDA guidance "A Risk-Based Approach to Monitoring of Clinical Investigations".